[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339974-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339974-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","malignant-pericardial-effusion-a-systematic-review","Malignant Pericardial Effusion - A Systematic Review","","Malignant pericardial effusion is often asymptomatic, with an unknown prevalence and frequent identification only after death. Due to its occult presentation and typically delayed recognition, evidence on epidemiology, clinical features, and patient outcomes remains limited. A systematic review was conducted after database searching. Case reports were included for adults with pericardial effusion in the setting of malignancy, with medical and/or surgical interventions, and mortality as the primary outcome.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/malignant-pericardial-effusion-a-systematic-review/339974/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/malignant-pericardial-effusion-a-systematic-review/339974.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is malignant pericardial effusion and why is it difficult to study?","Question",{"text":63,"@type":64},"It is frequently asymptomatic and often recognized only postmortem, making its prevalence and clinical course hard to quantify during life.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What criteria were used to include cases in the systematic review?",{"text":68,"@type":64},"Adults over 18 with pericardial effusion in the context of malignancy were included, with medical and/or surgical therapy and mortality reported as an outcome.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding symptoms, tamponade, and outcomes?",{"text":72,"@type":64},"Dyspnea was the leading symptom, cardiac tamponade was present in most cases, pericardiocentesis was common, and overall mortality was substantial.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339974,1790217281,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","CJC Open 6 (2024) 967e972  \nSystematic Review/Meta-analysis  \nMalignant Pericardial Effusion: A Systematic Review  \nSarah E. Mudra, MD,a, z Danny Rayes, MD,a, z Ashwin K. Kumar, MD,a,b Jason Z. Li, MD,a Meredith Njus, MD,a Kevin McGowan, MD,a Charalampos Charalampous, MD,a  \nKazi A. Kalam, MSc,a Alveena Syed, MD,b Muhammad Majid, MD,b Mary Schleicher, RN, BSN, MLIS,c Ankit Agrawal, MD,b Abdullah Yesilyaprak, MD,d and  \nAllan L. Klein, MDb  \na Department of Internal Medicine, MedStar Georgetown University Hospital, MedStar Health, Washington, DC, USA b Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular, and  \nThoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA  \nc Floyd D. Loop Memorial Library, Cleveland Clinic, Cleveland, Ohio, USA  \ndDepartment of Internal Medicine, Wayne State University, Detroit, Michigan, USA  \nABSTRACT  \nBackground: Malignant pericardial effusion (Eff) is often asymptomatic and has an unknown prevalence, due to its occult presentation. The condition often is identiﬁed postmortem on autopsy, and it is associated with a poor prognosis. Given the late presentation of malignant pericardial Effs, a minimal volume of literature has examined the epidemiology, clinical characteristics, and outcomes of these complex patients. We conducted a systematic review to advance present understanding of this condition.  \nMethods: A search of 4 databases resulted in 41 case reports meeting criteria. Inclusion criteria were being a patient aged > 18 years who presented with pericardial Eff in the setting of malignancy. Intervention was medical and/or surgical therapy, and the outcome was mortality.  \n􀀁 􀀁  \nRESUME  \nContexte : L’panchement pricardique malin (EPM) est un tat gnralement asymptomatique, de prvalence inconnue en raison de son tableau clinique occulte. Il est souvent reconnu post-mortem, à l’autopsie, et est associ à un pronostic mdiocre. En raison de la consultation tardive pour un EPM, les donnes publies relatives à l’pidmiologie, aux caractristiques cliniques et à l’issue de ces cas complexes sont limites. Nous avons ralis une analyse systmatiquedans le but d’largir les connaissances sur cette affection. Mthodologie : Une recherche ralise dans quatre bases de donnesa permis de reprer 41 rapports de cas qui rpondaient aux critères de recherche. Les critères d’inclusion taient les suivants : être âg de plus de 18 ans; prsenter un panchement pricardique en prsence  \nThe pericardial space is a site of metastatic spread in both solid and hematologic malignanciesdmost commonly those of the lung and breast, and lymphomas. Rarely, malignant pericardial effusions (Effs) result from primary cardiac and pericardial tumours.1-4 Pericardial involvement often is identiﬁed only postmortem. The estimated prevalence of malignant pericardial Effs is still disputed, but it may be as high as 20% .1-3 Presenting features vary with symptoms, dependent on Eff  \nReceived for publication February 16, 2024 . Accepted May 5, 2024 . zContributed equally.  \nCorresponding author: Dr Allan L. Klein, Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, 9500 Euclid Ave., Desk J1-5, Cleveland, Ohio 44195, USA. Tel.: (216) 444-3932; fax: (216) 444-6145 .  \nE-mail: [kleina@ccf.org](kleina@ccf.org)  \nSee page 972 for disclosure information.  \nsize, rapidity of accumulation, and evidence of cardiac tamponade (Tamp) .  \nThe precise mechanism of pericardial involvement remains uncertain, although it likely involves direct tumour invasion, hemorrhage, or hematogenous spread.1-3 Furthermore, treatment modalities, including radiation, chemotherapy, and immunotherapy, generate reactive oxygen species, which, in turn, activate neutrophils and predispose patients to pericardialinﬂammation.1-3  \nGiven the la","cbCaifjAZgaW6mjj","https://ap.wps.com/l/cbCaifjAZgaW6mjj","pdf",1254464,"English","# Abstract\n# Methods\n# Results\n# Conclusions\n# Search Strategy","[{\"question\":\"What is malignant pericardial effusion and why is it difficult to study?\",\"answer\":\"It is frequently asymptomatic and often recognized only postmortem, making its prevalence and clinical course hard to quantify during life.\"},{\"question\":\"What criteria were used to include cases in the systematic review?\",\"answer\":\"Adults over 18 with pericardial effusion in the context of malignancy were included, with medical and/or surgical therapy and mortality reported as an outcome.\"},{\"question\":\"What were the key findings regarding symptoms, tamponade, and outcomes?\",\"answer\":\"Dyspnea was the leading symptom, cardiac tamponade was present in most cases, pericardiocentesis was common, and overall mortality was substantial.\"}]","Malignant Pericardial Effusion - A Systematic Review | PDF",1790033441,15,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b980148faa6bfe48fabe96059b52f1c.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/945b3acaa6cd4ddffbccff541a64a5f3.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29f7292d01427326b8a93d39f126a0c1.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/432d9a401ee21b73096292576ae31727.webp",980,1311]